Jacek Grzybowski

535 total citations
9 papers, 407 citations indexed

About

Jacek Grzybowski is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jacek Grzybowski has authored 9 papers receiving a total of 407 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Cardiology and Cardiovascular Medicine and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jacek Grzybowski's work include Photodynamic Therapy Research Studies (2 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (1 paper) and Genomics and Rare Diseases (1 paper). Jacek Grzybowski is often cited by papers focused on Photodynamic Therapy Research Studies (2 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (1 paper) and Genomics and Rare Diseases (1 paper). Jacek Grzybowski collaborates with scholars based in Poland, United States and Italy. Jacek Grzybowski's co-authors include Alon Marmor, Beth Davison Weatherley, Sam L. Teichman, G. Michael Felker, Marco Metra, Gad Cotter, Piotr Ponikowski, Adriaan A. Voors, John R. Teerlink and Amos Katz and has published in prestigious journals such as The Lancet, Journal of Immunological Methods and Pharmacological Research.

In The Last Decade

Jacek Grzybowski

7 papers receiving 392 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jacek Grzybowski Poland 5 184 142 102 60 31 9 407
Werner Siekmeyer Germany 11 84 0.5× 37 0.3× 46 0.5× 15 0.3× 49 1.6× 32 293
Wojciech Kustrzycki Poland 10 145 0.8× 33 0.2× 81 0.8× 19 0.3× 58 1.9× 32 277
Abdi Bozkurt Türkiye 12 207 1.1× 17 0.1× 46 0.5× 11 0.2× 64 2.1× 33 348
Sophia Arapi Greece 11 228 1.2× 26 0.2× 34 0.3× 57 0.9× 25 0.8× 21 319
Bradley C. Clark United States 11 187 1.0× 29 0.2× 57 0.6× 55 0.9× 151 4.9× 43 398
Colm McParland Canada 11 136 0.7× 21 0.1× 274 2.7× 27 0.5× 56 1.8× 17 443
William Moir United States 10 33 0.2× 132 0.9× 102 1.0× 14 0.2× 13 0.4× 13 295
José Loureiro-Amigo Portugal 10 40 0.2× 39 0.3× 49 0.5× 13 0.2× 44 1.4× 37 260
Yves Martel Canada 4 120 0.7× 73 0.5× 11 0.1× 41 0.7× 66 2.1× 5 379
Munir Ahmed United Kingdom 8 32 0.2× 18 0.1× 63 0.6× 49 0.8× 130 4.2× 21 286

Countries citing papers authored by Jacek Grzybowski

Since Specialization
Citations

This map shows the geographic impact of Jacek Grzybowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacek Grzybowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacek Grzybowski more than expected).

Fields of papers citing papers by Jacek Grzybowski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacek Grzybowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacek Grzybowski. The network helps show where Jacek Grzybowski may publish in the future.

Co-authorship network of co-authors of Jacek Grzybowski

This figure shows the co-authorship network connecting the top 25 collaborators of Jacek Grzybowski. A scholar is included among the top collaborators of Jacek Grzybowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacek Grzybowski. Jacek Grzybowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Chmielewski, Przemysław, Grażyna Truszkowska, Mariusz Kłopotowski, et al.. (2025). PRKAG2 Syndrome: Clinical Features, Imaging Findings and Cardiac Events. Biomedicines. 13(3). 751–751.
3.
Teerlink, John R., Marco Metra, G. Michael Felker, et al.. (2009). Relaxin for the treatment of patients with acute heart failure (Pre-RELAX-AHF): a multicentre, randomised, placebo-controlled, parallel-group, dose-finding phase IIb study. The Lancet. 373(9673). 1429–1439. 307 indexed citations
4.
Grzybowski, Jacek, et al.. (2002). [Level of angiotensin II and aldosterone in plasma is often elevated in patients with heart failure treated with converting enzyme inhibitors--preliminary results].. PubMed. 59(8). 587–9. 2 indexed citations
6.
Grzybowski, Jacek, et al.. (1999). EXAMINATION OF ANTIBACTERIAL ACTIVITY OF THE PHOTOACTIVATED ARGININE HAEMATOPORPHYRIN DERIVATIVE. Pharmacological Research. 39(3). 181–184. 15 indexed citations
7.
Dobak, John, et al.. (1994). 1,25-Dihydroxyvitamin D3 increases collagen production in dermal fibroblasts. Journal of Dermatological Science. 8(1). 18–24. 45 indexed citations
8.
Grzybowski, Jacek, et al.. (1992). Antidietary Antigen Antibodies in the Sera of Patients with Burns as a Potential Marker of Gut Mucosa Integrity Failure. Journal of Burn Care & Rehabilitation. 13(2). 194–197. 1 indexed citations
9.
Grzybowski, Jacek, et al.. (1986). Enzyme-linked immunosorbent assay (ELISA) for the detection and differentiation of clostridium botulinum toxins type A and B. Journal of Immunological Methods. 93(2). 225–230. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026